KOSDAQChemicals453860

ASTech

₩5,350▼ 5.64%2026-11-18 close
Market Cap
₩34.5B
Turnover
₩34,302,690
Volume
6.4K
Shares out.
6.4M
PER
—
PBR
0.5×
EPS
-₩1,405
Dividend Yield
9.07%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩500 per share · Prices as of the 2026-11-18 close

01

Report overview

Sales Past Peak, Four Straight Loss-Making Quarters

ASTech's sales have fallen for two straight years since peaking in 2023, and operating losses have continued for four consecutive quarters through the third quarter of 2026.

  1. 1

    Sales peaked at KRW 47.3 billion in 2023, then fell to KRW 42.6 billion in 2024 and KRW 24.6 billion in 2025, a 42.3% drop in the latter year.

  2. 2

    The operating margin fell from 20.4% in 2024 to -0.4% in 2025, when ASTech swung to an operating loss of KRW 110 million.

  3. 3

    Over the latest four quarters, the net loss attributable to controlling shareholders totaled KRW 9 billion, with the largest quarterly loss of KRW 5.15 billion in the second quarter of 2026.

  4. 4

    Total equity stood at KRW 58.9 billion at the end of 2025 with a debt ratio of 83.2%, and whether losses persist is the key variable for the capital base.

  5. 5

    The price-to-book ratio sits below 1x, while the price-to-earnings ratio cannot be calculated because of the recent four quarters of net losses.

02

Business structure

ASTech, founded in 2005, manufactures cosmetic raw materials and develops raw materials for pharmaceuticals, with organic UV-filter ingredients as its core business.

Its main product is Uvimax DHHB, a UVA-blocking substance whose core technology was developed in May 2019 and first supplied to a global customer in 2020, according to coverage at the time of its listing. Revenue mix differs by data source.

WiseReport's breakdown for December 2025 shows UV-filter raw materials at 47.97%, CCS at 24.19% and others at 27.84%, while Butler's summary of second-quarter 2026 sales shows 74% and 26% for UV-filter materials and CCS. The two datasets use different dates and classifications, so direct comparison is limited.

In the WiseReport breakdown, CCS is classified as merchandise sales and recorded as 100% domestic. For UV-filter raw materials in 2025, domestic and export shares were 46.83% and 53.17%, so exports exceed half.

Coverage at listing described Germany's A company, ranked first in the UV-filter raw materials market, and DSM, ranked second, as customers; ASTech said it signed a four-year long-term supply contract with A company from 2020 and planned a five-year exclusive supply contract with DSM.

DHHB-related patents were registered in China in February 2025 and Taiwan in September 2025, and a TDSA-related patent was registered in Korea in October 2025. Coverage also says most sales come from DHHB, so both product and customer concentration are high.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩4.5B₩13,935,5670.3%
2025Q4₩6.1B-₩1.7B−28.4%
2026Q1₩4.6B-₩1.7B−37.8%
2026Q2₩4.3B-₩4.9B−115.0%
2026Q3₩3B-₩1.6B−53.4%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩32.2B₩4.5B₩1.8B14.0%48.0%809.5%
2023₩47.3B₩9.2B₩6.8B19.4%14.6%49.2%
2024₩42.6B₩8.7B₩9.5B20.4%16.8%58.5%
2025₩24.6B-₩100M₩2.2B−0.4%3.7%83.2%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-18

04

Earnings analysis

In the annual figures from regulatory filings, sales rose from KRW 32.2 billion in 2022 to KRW 47.3 billion in 2023, a 47.2% increase, making 2023 the largest year of 2022 to 2025. Sales then declined to KRW 42.6 billion in 2024, down 10.1%, and to KRW 24.6 billion in 2025, down 42.3%.

Operating profit was KRW 4.52 billion in 2022, KRW 9.17 billion in 2023 (up 103.0%) and KRW 8.7 billion in 2024 (down 5.1%), before a KRW 110 million operating loss in 2025 that turned the year from profit to loss.

The operating margin moved from 14.0% in 2022 to 19.4% in 2023 and 20.4% in 2024, then fell to -0.4% in 2025. Coverage of the 2025 filing attributed the swing to lower sales and the resulting drop in operating profit.

Net profit attributable to controlling shareholders peaked at KRW 9.48 billion in 2024, the largest year of 2022 to 2025, and fell to KRW 2.15 billion in 2025, down 77.3%.

Quarterly sales peaked at KRW 6.08 billion in the fourth quarter of 2025, up 33.9% from the prior quarter, yet that same quarter swung to an operating loss of KRW 1.73 billion.

Sales then declined for three consecutive quarters, to KRW 4.59 billion, KRW 4.26 billion and KRW 3.01 billion in the first through third quarters of 2026, with the third quarter down 33.7% year on year.

The operating loss was largest at KRW 4.89 billion in the second quarter of 2026 and narrowed to KRW 1.61 billion in the third quarter, but losses continued.

In the fourth quarter of 2025, the company posted an operating loss while net profit attributable to controlling shareholders was KRW 160 million, which suggests non-operating items played a role.

The debt ratio fell from 809.5% in 2022 to 83.2% in 2025, and operating cash flow dropped from KRW 12.4 billion in 2024 to KRW 2.89 billion in 2025 but stayed positive.

05

Industry analysis

ASTech's downstream market consists of cosmetics and pharmaceutical customers who make sun-care products, so raw material demand tends to move with sunscreen demand. In January 2024, Hana Securities said it expected supply to customers to keep rising on growing global sunscreen demand.

That view was a 2024 forecast, and sales did not follow the same direction, falling to KRW 42.6 billion in 2024 and KRW 24.6 billion in 2025. The raw material market is concentrated among a small group of global chemical companies and their customers, so volume and pricing can depend heavily on a few customers' orders.

On competition, the company has pointed to being the first domestic producer of its material, along with its patents and production capacity. A 2024 report described annual capacity doubling from 600 tons to 1,200 tons.

Meanwhile, quarterly sales have declined for three consecutive quarters through the third quarter of 2026, so whether demand is recovering will need to be confirmed in later quarterly results.

Customer inventory adjustments or timing shifts in orders may have amplified quarterly swings, but no filing in the material reviewed supports that explanation. Rather than stating where the cycle stands, it is more useful to watch where sales direction and operating margin settle after the fourth quarter of 2026.

Concentration in a few large customers means the company could benefit sharply from a demand recovery, but it also means that a change in orders can move results quickly.

06

Outlook

The one capacity plan that can be confirmed is the second plant. A February 2024 securities report expected the second plant to be completed in 2025, bringing combined capacity with the first plant to 2,400 tons. The same report converted that capacity to roughly KRW 150 billion, assuming KRW 60,000 per kilogram.

In January of the same year, Hana Securities forecast 2024 sales of KRW 63.8 billion, but the filed 2024 sales were KRW 42.6 billion. The gap suggests that the timing of new customer volumes, product mix and raw material prices differed from those forecasts.

Whether the second plant is actually running and how much of its capacity is used should be checked in the business report's facility and production section.

Coverage in 2023 described a planned five-year exclusive supply contract with DSM, but the actual volumes and when they will affect revenue are outside what the filings reviewed here show. The sales contribution of newer materials such as TDSA, EHT and BEMT is also not separately disclosed in the figures reviewed.

Fourth-quarter 2026 results have not yet been filed, so the nearest test is whether the three-quarter decline in sales continues into that quarter.

The 2026 annual business report will need to be read alongside the full-year operating loss, facility utilization and customer-level revenue to build a grounded view of the outlook.

On operating indicators, the key items are whether the 2026 operating margin improves from -0.4% in 2025 and whether the quarterly net loss attributable to controlling shareholders narrows.

07

Valuation

PER
—
PBR
0.5×
ROE
-14.8%
EPS
-₩1,405
BPS
₩11,235
Dividend per share
₩500

The price-to-book ratio is below 1x, meaning the share price sits at a discount to book value. Because the last four quarters were net losses, the price-to-earnings ratio cannot be calculated, so earnings-based multiples offer limited comparison and asset-based and dividend indicators take center stage.

Reading the dividend yield requires checking whether it reflects both a lower share price and lower earnings, and whether dividend funding can continue during a period of net losses.

At the end of 2025, total liabilities of KRW 49 billion were smaller than total equity of KRW 58.9 billion, and the debt ratio fell from 809.5% in 2022 to 83.2% in 2025.

However, financial stability in this phase depends on whether operating losses persist, so it is necessary to track how much quarterly net losses erode equity. Compared with the earlier stretch when the company moved from losses to profits, earnings recovery has not yet appeared in the filings.

The core of interpreting valuation is to see, through quarterly results, how the price-to-book ratio and dividend yield change once earnings recover.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-18

08

Bull factors

Technology and patent base

ASTech has been described as a company that first localized the Uvimax DHHB raw material in Korea. DHHB-related patents were registered in China in February 2025 and Taiwan in September 2025, and a TDSA-related patent in Korea in October 2025. Patent registrations that extend beyond the core product give the portfolio a broader base.

Capacity expansion headroom

A February 2024 securities report expected the second plant to be completed in 2025, bringing combined capacity to 2,400 tons, double the first plant's 1,200 tons. If operation is confirmed, production headroom could support a sales recovery when customer orders return. This is a bullish factor that depends on confirmation of actual operation.

Improving financial structure

The debt ratio fell from 809.5% in 2022 to 83.2% in 2025. At the end of 2025, total equity was KRW 58.9 billion against total liabilities of KRW 49 billion. Operating cash flow stayed positive at KRW 2.89 billion in 2025, so cash generation did not stop entirely during the loss period.

09

Bear factors

Consecutive sales declines

Sales fell from KRW 47.3 billion in 2023 to KRW 42.6 billion in 2024 and KRW 24.6 billion in 2025, a 42.3% drop in the latter year. Quarterly sales then declined for three consecutive quarters from the first quarter of 2026, with third-quarter sales of KRW 3.01 billion down 33.7% year on year.

Persistent quarterly losses

Operating losses have continued for four consecutive quarters from the fourth quarter of 2025 through the third quarter of 2026. The net loss attributable to controlling shareholders totaled KRW 9 billion over the latest four quarters, peaking at KRW 5.15 billion in the second quarter of 2026. The longer losses persist, the more the pace of equity erosion becomes the central question.

Gap between forecasts and results

In January 2024, Hana Securities forecast 2024 sales of KRW 63.8 billion, against filed 2024 sales of KRW 42.6 billion. A separate securities report projected KRW 63.5 billion for the same year. The wide gap suggests that assumptions about capacity and customer volume timing did not carry through to results.

10

Risk factors

Customer and product concentration

Coverage says most sales come from DHHB, and the main customers are known to be a small number of global companies. A cut in orders from one customer or the emergence of substitute materials could move sales sharply. The two consecutive years of declining sales are consistent with this concentrated structure.

Export exposure and external conditions

Exports accounted for 53.17% of UV-filter raw material sales in 2025, larger than the 46.83% domestic share. Overseas orders, exchange rates and foreign regulatory conditions can affect sales and profitability. The exposure can help in a recovery and weigh in a slowdown.

Erosion of financial cushion

The KRW 9 billion net loss over the latest four quarters is not small relative to total equity of KRW 58.9 billion at the end of 2025. Operating cash flow fell from KRW 12.4 billion in 2024 to KRW 2.89 billion in 2025, which means the cushion could erode quickly if losses continue. Whether there is funding to sustain dividends also needs to be examined.

11

What to watch next

  1. Early February 2027 (the 2025 annual results were filed on February 6, 2026)

    Full-year 2026 preliminary results and the fourth-quarter sales direction. The check is whether the three-quarter sales decline and four-quarter operating losses continue, and where the operating margin moves from -0.4% in 2025.

  2. By March 31, 2027 (business report filing deadline)

    The facility and production section of the 2026 business report. Items to confirm include whether the second plant is operating, capacity utilization, customer-level revenue mix and the breakdown of non-operating items.

  3. Around late March 2027 (annual general meeting season)

    Whether a dividend is declared and its size during the net-loss period. The check is whether the payout is funded from earnings and whether it is adjusted alongside the decline in equity.

  4. Timing undetermined (when ad hoc disclosures are made)

    Ad hoc disclosures such as the start of the DSM exclusive supply contract, new supply contracts for TDSA, EHT and BEMT, or changes to the expansion schedule. The check is whether these support a change in the sales trajectory.

12

Overall view

ASTech specializes in UV-filter raw materials. Sales fell in both 2024 and 2025 after peaking at KRW 47.3 billion in 2023, and the company swung to an operating loss in 2025.

Quarterly sales have also declined for three consecutive quarters into 2026, and operating losses have continued for four consecutive quarters from the fourth quarter of 2025 through the third quarter of 2026.

Bullish factors include the expansion of DHHB-related patent registrations, production headroom from the planned second plant, a lower debt ratio and positive operating cash flow.

Bearish factors include concentration of most sales in DHHB, a KRW 9 billion net loss attributable to controlling shareholders over the latest four quarters, and a large gap between the 2024 forecasts and actual sales.

The price-to-book ratio sits below 1x, but with no earnings-based multiple available, valuation rests mainly on asset and dividend indicators. The next checkpoints are the fourth-quarter 2026 preliminary results and the facility utilization and customer mix in the 2026 business report. This report is for information only and does not express an investment opinion, rating or target price.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. comp.wisereport.co.kr
  2. butler.works
  3. news.nate.com
  4. hanaw.com
  5. ssl.pstatic.net
  6. newswell.co.kr
  7. thevc.kr
  8. m.thinkpool.com
  9. vegannews.co.kr
  10. judal.co.kr
  11. globenewswire.com
  12. investing.com
  13. judal.co.kr
  14. bosoop.com
  15. judal.co.kr
  16. judal.co.kr
  17. jobkorea.co.kr
  18. judal.co.kr

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis